Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Reviews in Endocrine & Metabolic Disorders
|
August 21, 2024
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy
Sabrina Chiloiro, Alessandra Vicari, Ginevra Mongelli, et al.
Pituitary
|
July 11, 2026
The metabolic effects of glucocorticoid replacement therapy in patients with secondary adrenal insufficiency due to hypothalamic-pituitary diseases: results from a retrospective and longitudinal study
Sabrina Chiloiro, Alessandra Vicari, Antonella Giampietro, et al.
Frontiers in Endocrinology
|
September 16, 2024
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study
Sabrina Chiloiro, Flavia Costanza, Antonella Giampietro, et al.
Pituitary
|
January 19, 2026
Long-term effect on bone mineral density of denosumab in the treatment of hyperpituitarism driven osteoporosis: an exploratory study
Sabrina Chiloiro, Flavia Costanza, Alessandra Vicari, et al.
Pituitary
|
May 25, 2025
Genes of the "regulation of lymphocyte activation" pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors
Sabrina Chiloiro, Flavia Costanza, Giovanni Luca Scaglione, et al.
Pituitary
|
December 26, 2024
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly
Sabrina Chiloiro, Antonella Giampietro, Penelope Giambò, et al.
Pituitary
|
September 7, 2025
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort
Sabrina Chiloiro, Antonella Giampietro, Raffaele Migliore, et al.
International Journal of Molecular Sciences
|
February 10, 2024
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?
Sabrina Chiloiro, Ettore Domenico Capoluongo, Flavia Costanza, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
July 1, 2026
Clinical Exome Sequencing Study in a Cohort of Growth Hormone-Secreting Pituitary Adenomas
Flavia Costanza, Giovanni Luca Scaglione, Filippo Russo, et al.
BMC Cancer
|
March 21, 2020
MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia
Matteo Floris, Daria Sanna, Paolo Castiglia, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Reviews in Endocrine & Metabolic Disorders
|
August 21, 2024
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy
Sabrina Chiloiro, Alessandra Vicari, Ginevra Mongelli, et al.
Pituitary
|
July 11, 2026
The metabolic effects of glucocorticoid replacement therapy in patients with secondary adrenal insufficiency due to hypothalamic-pituitary diseases: results from a retrospective and longitudinal study
Sabrina Chiloiro, Alessandra Vicari, Antonella Giampietro, et al.
Frontiers in Endocrinology
|
September 16, 2024
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study
Sabrina Chiloiro, Flavia Costanza, Antonella Giampietro, et al.
Pituitary
|
January 19, 2026
Long-term effect on bone mineral density of denosumab in the treatment of hyperpituitarism driven osteoporosis: an exploratory study
Sabrina Chiloiro, Flavia Costanza, Alessandra Vicari, et al.
Pituitary
|
May 25, 2025
Genes of the "regulation of lymphocyte activation" pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors
Sabrina Chiloiro, Flavia Costanza, Giovanni Luca Scaglione, et al.
Pituitary
|
December 26, 2024
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly
Sabrina Chiloiro, Antonella Giampietro, Penelope Giambò, et al.
Pituitary
|
September 7, 2025
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort
Sabrina Chiloiro, Antonella Giampietro, Raffaele Migliore, et al.
International Journal of Molecular Sciences
|
February 10, 2024
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?
Sabrina Chiloiro, Ettore Domenico Capoluongo, Flavia Costanza, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
July 1, 2026
Clinical Exome Sequencing Study in a Cohort of Growth Hormone-Secreting Pituitary Adenomas
Flavia Costanza, Giovanni Luca Scaglione, Filippo Russo, et al.
BMC Cancer
|
March 21, 2020
MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia
Matteo Floris, Daria Sanna, Paolo Castiglia, et al.
Page
of 3